We recommend you to makes use of Neuland Laboratories Limited fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this interface allows you to check out available financial ratios of Neuland Laboratories as well as the relationship between them. We found twenty-five available fundamentals for Neuland Laboratories which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Neuland Laboratories Limited fundamentals including its Net Income and the relationship between Total Debt and Number of Employees .
Neuland Laboratories Company Summary
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients in India and internationally.
Neuland Laboratories Operating Margin vs Debt to Equity
Neuland Laboratories Limited is considered to be number one stock in operating margin category among related companies. It is considered to be number one stock in debt to equity category among related companies fabricating about 0.26 of Debt to Equity per Operating Margin. The ratio of Operating Margin to Debt to Equity for Neuland Laboratories Limited is roughly 3.89
Neuland Laboratories Market Fundamentals
Neuland Laboratories Financial Distress Probability
Chance of Financial Distress
Neuland Laboratories Limited has less than 40 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Please see also Stocks Correlation. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.